Metals in Alzheimer's Disease.

Area of Science:

• Neuroscience
• Environmental Health
• Biochemistry

Background:

• The link between metal dysregulation and Alzheimer's disease (AD) pathogenesis is an area of ongoing investigation.
• Both essential metal imbalances and environmental heavy metal exposure have been implicated in AD development.

Purpose of the Study:

• To review human studies examining the relationship between metal concentrations and Alzheimer's disease.
• To synthesize findings on metal levels in AD patients versus controls, correlations with cerebrospinal fluid (CSF) biomarkers, and Mendelian randomization (MR) analyses.

Main Methods:

• Systematic review of human studies comparing metal concentrations in AD patients and healthy controls.
• Analysis of studies correlating AD cerebrospinal fluid (CSF) biomarkers with metal concentrations.
• Inclusion of Mendelian randomization (MR) studies assessing metal contributions to AD risk.

Main Results:

• Inconsistent findings across studies examining various metals in dementia patients.
• Most consistent observations include decreased zinc (Zn) and increased copper (Cu) levels in AD patients, though some studies report no association.
• Limited research exists correlating metal levels with CSF biomarkers in AD.

Conclusions:

• Understanding metal dynamics in Alzheimer's disease remains challenging due to conflicting study results.
• Further research is needed to clarify the relationship between metal levels and AD biomarkers.
• Additional Mendelian randomization (MR) studies across diverse populations are critical to establish causal links between metals and AD risk.